BDBM273463 US10071079, Example 246::US10478424, Example 246

SMILES: CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1

InChI Key: InChIKey=RVHKVNUNGDROIX-UHFFFAOYSA-N

Data: 6 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 273463   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Toll-like receptor 7 (Homo sapiens (Human))	BDBM273463 (US10071079, Example 246 | US10478424, Example 246) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1 Show InChI InChI=1S/C28H37N5O/c1-17(2)25-23-14-21(20-9-11-32(12-10-20)16-28(5,6)34)7-8-24(23)30-26(25)22-13-18(3)27-29-19(4)31-33(27)15-22/h7-8,13-15,17,20,30,34H,9-12,16H2,1-6H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.200	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair
Toll-like receptor 8 (Homo sapiens (Human))	BDBM273463 (US10071079, Example 246 | US10478424, Example 246) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1 Show InChI InChI=1S/C28H37N5O/c1-17(2)25-23-14-21(20-9-11-32(12-10-20)16-28(5,6)34)7-8-24(23)30-26(25)22-13-18(3)27-29-19(4)31-33(27)15-22/h7-8,13-15,17,20,30,34H,9-12,16H2,1-6H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.30	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair
Toll-like receptor 9 (Homo sapiens (Human))	BDBM273463 (US10071079, Example 246 | US10478424, Example 246) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1 Show InChI InChI=1S/C28H37N5O/c1-17(2)25-23-14-21(20-9-11-32(12-10-20)16-28(5,6)34)7-8-24(23)30-26(25)22-13-18(3)27-29-19(4)31-33(27)15-22/h7-8,13-15,17,20,30,34H,9-12,16H2,1-6H3	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.26E+3	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 7 (Homo sapiens (Human))	BDBM273463 (US10071079, Example 246 | US10478424, Example 246) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1 Show InChI InChI=1S/C28H37N5O/c1-17(2)25-23-14-21(20-9-11-32(12-10-20)16-28(5,6)34)7-8-24(23)30-26(25)22-13-18(3)27-29-19(4)31-33(27)15-22/h7-8,13-15,17,20,30,34H,9-12,16H2,1-6H3	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	0.200	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 8 (Homo sapiens (Human))	BDBM273463 (US10071079, Example 246 | US10478424, Example 246) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1 Show InChI InChI=1S/C28H37N5O/c1-17(2)25-23-14-21(20-9-11-32(12-10-20)16-28(5,6)34)7-8-24(23)30-26(25)22-13-18(3)27-29-19(4)31-33(27)15-22/h7-8,13-15,17,20,30,34H,9-12,16H2,1-6H3	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.30	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10478424 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2DB0
					More data for this Ligand-Target Pair
Toll-like receptor 9 (Homo sapiens (Human))	BDBM273463 (US10071079, Example 246 | US10478424, Example 246) Show SMILES CC(C)c1c([nH]c2ccc(cc12)C1CCN(CC(C)(C)O)CC1)-c1cc(C)c2nc(C)nn2c1 Show InChI InChI=1S/C28H37N5O/c1-17(2)25-23-14-21(20-9-11-32(12-10-20)16-28(5,6)34)7-8-24(23)30-26(25)22-13-18(3)27-29-19(4)31-33(27)15-22/h7-8,13-15,17,20,30,34H,9-12,16H2,1-6H3	UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.26E+3	n/a	n/a	n/a	n/a	n/a	25
Bristol-Myers Squibb Company US Patent					Assay Description HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...				US Patent US10071079 (2018) BindingDB Entry DOI: 10.7270/Q2VD71GV
					More data for this Ligand-Target Pair